T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
F5
FFIV
$24B
| $17.5M | ﹤0.01% |
94,010
-1,400
| -1% | -$269K |
|
1327
IPG Photonics
IPGP
$3.71B
| $17.5M | ﹤0.01% |
82,931
-1,100
| -1% | -$232K |
|
1328
Essential Utilities
WTRG
$11.3B
| $17.4M | ﹤0.01% |
380,449
-7,906
| -2% | -$371K |
|
|
CMA
1329
DELISTED
Comerica
CMA
| $17.3M | ﹤0.01% |
242,557
-8,800
| -4% | -$652K |
|
1330
Newell Brands
NWL
$2.62B
| $17.2M | ﹤0.01% |
627,218
-20,723
| -3% | -$571K |
|
1331
Norwegian Cruise Line
NCLH
$8.69B
| $17.2M | ﹤0.01% |
584,380
-6,133
| -1% | -$185K |
|
1332
Pulmonx
LUNG
$98.4M
| $17.2M | ﹤0.01% |
389,527
-328,396
| -46% | -$14.3M |
|
1333
Bloom Energy
BE
$69.6B
| $17M | ﹤0.01% |
632,829
+66,355
| +12% | +$1.61M |
|
1334
Pentair
PNR
$10.5B
| $16.9M | ﹤0.01% |
250,736
-2,700
| -1% | -$179K |
|
1335
CVRx
CVRX
$78.3M
| $16.8M | ﹤0.01% |
+600,000
| New | +$16.8M |
|
|
AGFS
1336
DELISTED
AgroFresh Solutions Inc
AGFS
| $16.8M | ﹤0.01% |
8,060,330
-16,219
| -0.2% | -$34.9K |
|
|
PRDS
1337
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $16.7M | ﹤0.01% |
1,668,633
-42,222
| -2% | -$424K |
|
1338
iShares Core S&P 500 ETF
IVV
$910B
| $16.5M | ﹤0.01% |
38,491
+4,799
| +14% | +$2.01M |
|
1339
State Street Blackstone Senior Loan ETF
SRLN
$5.38B
| $16.5M | ﹤0.01% |
357,100
| – | – |
|
1340
Everest Group
EG
$13.9B
| $16.5M | ﹤0.01% |
65,582
-216
| -0.3% | -$56.2K |
|
1341
Q32 Bio
QTTB
$458M
| $16.5M | ﹤0.01% |
125,814
-23,723
| -16% | -$2.96M |
|
|
BNR
1342
Burning Rock Biotech
BNR
$105M
| $16.4M | ﹤0.01% |
55,733
-16,734
| -23% | -$4.95M |
|
1343
iShares Core MSCI EAFE ETF
IEFA
$196B
| $16.3M | ﹤0.01% |
217,952
-299,874
| -58% | -$22.6M |
|
1344
Pinnacle West Capital
PNW
$12.2B
| $16.2M | ﹤0.01% |
198,105
-3,883
| -2% | -$328K |
|
1345
Ambev
ABEV
$43.5B
| $16.2M | ﹤0.01% |
4,710,600
| – | – |
|
|
STOR
1346
DELISTED
STORE Capital Corporation
STOR
| $16.1M | ﹤0.01% |
467,959
+10,635
| +2% | +$370K |
|
1347
Hydrofarm Holdings
HYFM
$8.58M
| $16.1M | ﹤0.01% |
27,185
+10,085
| +59% | +$5.93M |
|
|
MRO
1348
DELISTED
Marathon Oil Corporation
MRO
| $15.8M | ﹤0.01% |
1,158,086
-2,822,787
| -71% | -$34.1M |
|
1349
Molson Coors Class B
TAP
$7.75B
| $15.8M | ﹤0.01% |
293,500
-4,930
| -2% | -$275K |
|
1350
Natera
NTRA
$45.5B
| $15.7M | ﹤0.01% |
138,647
+102,345
| +282% | +$10.5M |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.